Danaher Future Growth
Future criteria checks 1/6
Danaher is forecast to grow earnings and revenue by 11.3% and 5.7% per annum respectively. EPS is expected to grow by 11.4% per annum. Return on equity is forecast to be 10.5% in 3 years.
Key information
11.3%
Earnings growth rate
11.4%
EPS growth rate
| Life Sciences earnings growth | 15.8% |
| Revenue growth rate | 5.7% |
| Future return on equity | 10.5% |
| Analyst coverage | Good |
| Last updated | 17 Apr 2024 |
Recent future growth updates
Recent updates
Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11
Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price
Sep 30Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well
Jul 13Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Jun 28Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?
Jun 15Danaher: A Great Chance To Buy This Long-Term Compounder
May 23With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case
Apr 26Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Mar 28Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?
Mar 15Is Danaher (NYSE:DHR) Using Too Much Debt?
Mar 02Danaher ups dividend by 8% to $0.27
Feb 22Danaher Q4 2022 Earnings Preview
Jan 23Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?
Jan 16We Have A Winner! Revisiting Danaher And Thermo Fisher
Jan 11Danaher downgraded to neutral at Credit Suisse on exposure to inventory reductions
Jan 05A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)
Dec 18Danaher: A Great Business - The Price Where I Would Buy
Dec 14Danaher declares $0.25 dividend
Dec 06When Should You Buy Danaher Corporation (NYSE:DHR)?
Dec 04Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?
Nov 20Danaher Q3 2022 Earnings Preview
Oct 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 28,136 | 5,864 | 6,716 | 7,896 | 15 |
| 12/31/2025 | 26,101 | 5,381 | 6,283 | 7,385 | 25 |
| 12/31/2024 | 24,028 | 4,485 | 5,643 | 6,643 | 23 |
| 12/31/2023 | 23,890 | 4,200 | 5,781 | 7,164 | N/A |
| 9/29/2023 | 29,566 | 5,874 | 6,776 | 8,086 | N/A |
| 6/30/2023 | 30,356 | 6,296 | 7,202 | 8,424 | N/A |
| 3/31/2023 | 30,950 | 6,848 | 7,321 | 8,498 | N/A |
| 12/31/2022 | 26,643 | 6,222 | 7,401 | 8,519 | N/A |
| 9/30/2022 | 31,250 | 6,640 | 7,068 | 8,311 | N/A |
| 7/1/2022 | 30,816 | 6,206 | 7,051 | 8,335 | N/A |
| 4/1/2022 | 30,283 | 6,206 | 7,162 | 8,455 | N/A |
| 12/31/2021 | 24,802 | 5,283 | 7,118 | 8,358 | N/A |
| 10/1/2021 | 28,065 | 5,636 | 7,056 | 8,246 | N/A |
| 7/2/2021 | 26,720 | 5,361 | 6,876 | 7,935 | N/A |
| 4/2/2021 | 24,799 | 4,595 | 6,351 | 7,260 | N/A |
| 12/31/2020 | 22,284 | 3,510 | 5,417 | 6,208 | N/A |
| 10/2/2020 | 20,392 | 3,083 | 4,444 | 5,099 | N/A |
| 7/3/2020 | 18,886 | 2,853 | 3,712 | 4,341 | N/A |
| 4/3/2020 | 18,034 | 2,614 | 3,439 | 4,068 | N/A |
| 12/31/2019 | 17,911 | 2,364 | 3,316 | 3,952 | N/A |
| 9/27/2019 | 15,562 | 2,093 | 3,479 | 4,078 | N/A |
| 6/28/2019 | 16,037 | 2,145 | 3,446 | 4,032 | N/A |
| 3/29/2019 | 16,573 | 2,166 | 3,311 | 3,896 | N/A |
| 12/31/2018 | 17,049 | 2,406 | 3,438 | 4,022 | N/A |
| 9/28/2018 | 19,615 | 2,761 | 3,004 | 3,619 | N/A |
| 6/29/2018 | 19,290 | 2,669 | 3,167 | 3,772 | N/A |
| 3/30/2018 | 18,819 | 2,553 | 3,148 | 3,747 | N/A |
| 12/31/2017 | 15,519 | 2,172 | 2,907 | 3,478 | N/A |
| 9/29/2017 | 17,828 | 2,360 | N/A | 3,292 | N/A |
| 6/30/2017 | 17,432 | 2,191 | N/A | 3,038 | N/A |
| 3/31/2017 | 17,164 | 2,051 | N/A | 3,309 | N/A |
| 12/31/2016 | 16,882 | 2,153 | N/A | 3,522 | N/A |
| 9/30/2016 | 16,621 | 1,927 | N/A | 4,104 | N/A |
| 7/1/2016 | 16,001 | 1,905 | N/A | 4,239 | N/A |
| 4/1/2016 | 13,663 | 1,775 | N/A | 4,051 | N/A |
| 12/31/2015 | 14,434 | 1,747 | N/A | 3,802 | N/A |
| 10/2/2015 | 15,335 | 1,875 | N/A | 3,810 | N/A |
| 7/3/2015 | 16,530 | 2,177 | N/A | 3,873 | N/A |
| 4/3/2015 | 19,186 | 2,521 | N/A | 3,771 | N/A |
| 12/31/2014 | 12,867 | 1,639 | N/A | 3,758 | N/A |
| 9/26/2014 | 19,197 | 2,683 | N/A | 3,597 | N/A |
| 6/27/2014 | 19,159 | 2,599 | N/A | 3,553 | N/A |
| 3/28/2014 | 19,336 | 2,583 | N/A | 3,460 | N/A |
| 12/31/2013 | 18,283 | 2,591 | N/A | 3,585 | N/A |
| 9/27/2013 | 18,827 | 2,536 | N/A | 3,307 | N/A |
| 6/28/2013 | 18,573 | 2,488 | N/A | 3,297 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DHR's forecast earnings growth (11.3% per year) is above the savings rate (2.3%).
Earnings vs Market: DHR's earnings (11.3% per year) are forecast to grow slower than the US market (14.4% per year).
High Growth Earnings: DHR's earnings are forecast to grow, but not significantly.
Revenue vs Market: DHR's revenue (5.7% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: DHR's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DHR's Return on Equity is forecast to be low in 3 years time (10.5%).